Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease
about
Immunosenescence and organ transplantationAdvances in predicting acute GVHDThe Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical OverviewWho is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?Aging impairs recipient T cell intrinsic and extrinsic factors in response to transplantationMechanisms and consequences of injury and repair in older organ transplantsEffects of cellular sensitization and donor age on acute rejection and graft function after deceased-donor kidney transplantation.Immunosenescence and immune response in organ transplantation.Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life.Characterization of regulatory dendritic cells that mitigate acute graft-versus-host disease in older mice following allogeneic bone marrow transplantation.New strategies for prevention and treatment of graft-versus-host disease and for induction of graft-versus-leukemia effects.Aging Impairs the Ability of Conventional Dendritic Cells to Cross-Prime CD8+ T Cells upon Stimulation with a TLR7 Ligand.CD11c+ Dendritic Cells Accelerate the Rejection of Older Cardiac Transplants via Interleukin-17AAge-dependent response of murine female bone marrow cells to hyperbaric oxygenReduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.The molecular and cellular aspects of arthritis due to alphavirus infections: lesson learned from Ross River virus.Dendritic cells and acute graft-versus-host disease after allogeneic stem cell transplantation.Principles of bone marrow transplantation (BMT): providing optimal veterinary and husbandry care to irradiated mice in BMT studies.Acute graft-versus-host disease: from the bench to the bedside.IL-12hi rapamycin-conditioned dendritic cells mediate IFN-γ-dependent apoptosis of alloreactive CD4+ T cells in vitro and reduce lethal graft-versus-host disease.The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant.Mouse models of graft-versus-host disease: advances and limitationsDonor age-specific injury and immune responses.Impact of immunosenescence on transplant outcome.Advances in conditioning regimens for older adults undergoing allogeneic stem cell transplantation to treat hematologic malignancies.Preclinical modeling of hematopoietic stem cell transplantation - advantages and limitations.Aging and the immune response to organ transplantation.Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.Assessing the potential role of photopheresis in hematopoietic stem cell transplant.Phenotype and functions of conventional dendritic cells are not compromised in aged mice.Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus.Chronic Graft-Versus-Host Disease in Children
P2860
Q26861735-7B33985C-D61F-4594-9D17-140F96065A47Q27021123-6D526255-873B-4BA1-91E8-88A3C608E157Q28066083-8186C15F-73A2-4C7B-A4B8-2406BA56581AQ30414156-3AA10C90-C4F7-4E62-81AE-70C7BDAAA23BQ33396930-7FB97B6E-253A-43AE-9C82-FFC66116C85DQ33700247-BC814E47-A2FF-4448-8C2A-675D90670BF6Q33824958-5D37359D-46FB-4A9A-9E91-AAC2BDDDDBD0Q33872432-C4B9E51E-C089-4817-97FD-A9356C1F5421Q34667853-63ECDF2B-C37E-4CFC-BEC9-22E0492E04D1Q34990554-8C33DDD6-2564-4A8D-8D97-121CBE5C1F60Q35060005-9783C735-8BC8-4C54-BBC1-DC5FF64BF74BQ35810437-6E8AEC56-782C-4CCB-BB96-C795028BB36CQ35855318-48EFFC3B-EE22-4761-9EC8-5F286E87CD96Q35989840-7ADDCB67-35E4-4CC7-93A5-8A3BB49C23FEQ36219724-C3CA7C90-8272-431B-942C-74CB437B9C6EQ36807263-E4442E73-6BFE-445D-A40C-896BBDD53222Q36929664-53167776-3593-4B25-B2CF-BB0355911297Q37223312-61FB6546-2E04-46F0-B57F-5EBFB2C1ECF2Q37420496-E8A7A663-CB5E-4145-93CD-F5FA67D1F763Q37661441-FF2A8DF6-8FB1-49E0-8FAE-38DB9492289EQ37689179-A88BDBFE-C0EE-4272-A4A8-8779F43C8118Q37874011-7197D122-D1DF-4060-85C3-677CCE3D4C1BQ37952779-6FF2FCD6-D978-4459-AC20-F83AB185FFDCQ38063349-07951724-00A5-485C-A88F-031F4CC8FAD7Q38095833-9FE83C95-ACF7-4495-93D0-2DCCE33F0104Q38660463-0372A892-FAE6-4B3E-8763-42B643EBEB4BQ38683846-B50F6390-0388-4EA4-B842-C39921491E80Q39002164-66A74AB1-A237-46DF-B52F-9C433E24616CQ42693455-1DED949E-9859-4CE3-AD72-BA8062D73C1AQ43615736-F19367F4-528B-42F7-85FE-68F5AF047D66Q44750611-18D70906-6ACC-4D1F-A36E-A53B93239857Q59094154-08EFF013-EB1F-48FF-AD46-BBB5F3009AA0
P2860
Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Enhanced allostimulatory activ ...... cute graft-versus-host disease
@ast
Enhanced allostimulatory activ ...... cute graft-versus-host disease
@en
Enhanced allostimulatory activ ...... cute graft-versus-host disease
@nl
type
label
Enhanced allostimulatory activ ...... cute graft-versus-host disease
@ast
Enhanced allostimulatory activ ...... cute graft-versus-host disease
@en
Enhanced allostimulatory activ ...... cute graft-versus-host disease
@nl
prefLabel
Enhanced allostimulatory activ ...... cute graft-versus-host disease
@ast
Enhanced allostimulatory activ ...... cute graft-versus-host disease
@en
Enhanced allostimulatory activ ...... cute graft-versus-host disease
@nl
P2093
P2860
P1476
Enhanced allostimulatory activ ...... cute graft-versus-host disease
@en
P2093
James L M Ferrara
Jeffrey Friedman
Pavan Reddy
Rainer Ordemann
Raymond Hutchinson
Thomas M Braun
Ulrich Duffner
P2860
P304
P356
10.1172/JCI0214793
10.1172/JCI14793
P407
P577
2002-05-01T00:00:00Z